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Clinical manifestations of COVID-19 in children are milder, but the real burden of disease is unknown. After the
lockdown, in our Region Lombardia we have been requested to progressively resume medical services including
outpatient assessment and priority surgery. Therefore, we screened surgical waiting lists with identification of 47
children candidates to priority surgery (among 358). No homogeneous national health surveillance/screening
programs are ongoing or have been conceived to test susceptible population among children/healthcare workers
in preparation of coming down to routinely daily activities, and diagnostic strategies are not completely accurate
in children. So, restoring medical services now might be untimely.
Clinical manifestations of coronavirus 2019 disease (COVID-19) in
children are considered to be milder than in adults, given that fever,
cough, and respiratory fatigue have been reported in 73% of affected
children compared to 93% of adults [1], with severe/critical disease
developing in 6% [2]. In Italy about 4% of affected children (mainly
those younger than two years) required hospital admission, and no fatal
outcome occurred [3].
Reasons for different susceptibility are unknown, and they may be
possibly ascribable to the relatively immature and inexperienced im-
mune system, reduced SARS-CoV-2 tropism across pediatric upper
airway (ACE2 receptors are upregulated by smoking, hypertension, and
COPD) [2], anatomic barrier exerted by hypertropic lymphoid tissue
overwhelming respiratory epithelial viral binding sites.
However, gastrointestinal complaints are comparable in pediatric
and adult case-series. Some reports have been recently received re-
garding the possible association between pediatric multi-systemic in-
flammatory syndrome and SARS-CoV-2 infection [4], and new findings
suggest that bacterial superinfection would be more frequent in chil-
dren [5]. So, clinical pattern of presentation of pediatric COVID-19 is
still evolving and the real burden of disease in the pediatric age is not
completely understood, but all that prompt us to question about the
truth of the assumption that susceptibility and aggressiveness of SARS-
CoV-2 would be reduced in children.
In Italy, and in particular in our Region Lombardia, since the be-
ginning of COVID-19 breakdown at the end of February, any medical
activity other than those related to emergency or judged to be of critical
importance for the patients well-being have been postponed, including
any pediatric ENT activities. Immediately after the lockdown, on May
4th, we have been requested to progressively resume medical services
including outpatient assessment and to plan surgery for children with
ENT surgical priority (i.e. to be treated within 60 days). The Italian
Society of Otolaryngology and Head and Neck Surgery gave some
practical recommendations for the management of children with ENT
disease [6], by limiting outpatient visit to the sole urgent cases or those
requiring short-term evaluation on the basis of priority on regional
recipe. Adenotonsillectomy for children with severe obstructive sleep
apnoea syndrome (OSAS), cochlear implantation, and surgery for per-
sistent otitis media with effusion (OME) determining negative impact
on language were considered the only elective surgical procedures to be
planned [6] (priority surgery). Before COVID-19 era, our pediatric ENT
surgical waiting list categorized patients as: A) children to be operated
within 30 days; B) children to be operated within 60 days; C) children
in whom surgery could be performed in the medium/long-term (>60
days). Code A mainly included children with: large adenotonsillar hy-
pertrophy with documented OSAS or suspected OSAS in syndromic
disease; adenoidal hypertrophy with persistent OME and bilateral
hearing impairment with language acquisition delay; adenoidal hy-
pertrophy with tympanic membrane atelectasis and hearing impair-
ment; large asymmetric tonsillar hypertrophy; middle ear cholestea-
toma. Code B mainly included adenotonsillar hypertrophy with very
frequent infections requiring monthly antibiotic prescription or anti-
biotic prophylaxis during winter; recurrent acute tonsillitis in children
with periodic fever-aphthous stomatitis-pharyngitis–adenopathy syn-
drome; previous peritonsillar abscess.
To follow the national strategic plan [6], we screened our surgical
waiting lists considering these parameters. To achieve this result, the
recent (< 90 days) medical records of patients were assessed when
available; if not, telemedicine by means of telephone call by a resident
physician was used. This lead to identification of 47 children candidates
to priority surgery among 358 children globally waiting for surgery,
and to update our surgical waiting list on the basis of clinical im-
provement/recovery or parents’ decision to avoid/postpone surgery
(152 children dropping out for subjective improvement, request for
pediatric or ENT revaluation, surgery yet performed elsewhere)
(Table 1).
Sixteen children (34%) selected for priority surgery should undergo
microdebrider-assisted extracapsular tonsillotomy, but recent interna-
tional recommendations suggest to avoid the use of powered
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instrumentation in order to reduce aerosol generation [7] thus opening
the way to restoration of traditional tonsillectomy; at the same time,
powered-assisted adenoidectomy could give way to traditional cold
adenoidectomy with potential impact in terms of peritubaric adenoidal
recurrence [8].
With regard to the recovery of outpatient medical activity, it should
be considered that upper respiratory tract infections are extremely
frequent in the pediatric age, especially in children with adenoiditis,
and they are completely indiscernible from COVID-19 respiratory
complaints. In Italy about 3750 pediatric cases have been reported,
most of whom (68.93%) occurring in children aged 7–17 years [3].
However, the real prevalence of SARS-CoV-2 infection among children
is unknown and probably largely underestimated given the presumably
high rate of asymptomatic carriers. So far, no homogeneous national
health surveillance or screening programs are currently ongoing or
have been conceived to test susceptible population among children and
healthcare workers in preparation of coming down to routinely daily
activities. Furthermore, non-serologic diagnosis is not completely ac-
curate in the pediatric age. In particular, nasopharyngeal swab execu-
tion in children is not so simple given the fact that reduced compliance
during this unpleasant manouvre could result in swab contamination,
inadequate collection into the nasal fossa rather than the nasopharynx,
thus accounting for false negative results or bleeding. Dispersal or
aerosolized infected droplets with nosocomial transmission is another
important drawback especially in children where inhibition of cough
reflex is ineffective. Non-enhanced chest computed tomography (CT)
has been considered in the Dutch pre-operative guidelines as an option
to assess the COVID-19 status in the adult patients [9]. Given the dif-
ficulty in identifying infected children without respiratory complaints
and select among them candidates for routine clinical activities, a paper
recently published on the flagship scientific journal of the European
Respiratory Society focused about the role of chest CT as screening tool
in the pediatric age [10]. The Authors [10] concluded that a negative
CT finding does not rule out SARS-CoV-2 lung infection, and therefore
this diagnostic modality should not be used to screen children with no
or mild respiratory symptoms.
In addition, diagnostic strategies should be applied not only to the
patients but also to caregivers and relatives, given that the adherence to
hygienic measure of infection control and social distancing are difficult
to be applied in the pediatric age.
Under these circumstances, particularly in regions with a remark-
able SARS-CoV-2 circulation, are we sure to be ready to start again?
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Table 1
Categorization of patients placed under surgical waiting list before COVID-19
breakdown and during pandemic.
Code No. of patients
Pre-COVID-19 A 41
B 300
C 17
Tot. 358
During COVID-19 Priority surgery 47
Non-priority surgery 159
Tot. 206
Dropped out 152
Tot. 358
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